Analyst Reco. Cue Health Inc.

Equities

Market Closed - OTC Markets Other stock markets 02:54:40 2026-04-10 pm EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	-

24-11-05	Motion for Asset Sale Approved for Cue Health Inc.	CI
24-07-29	Motion for Asset Sale Approved for Cue Health Inc.	CI

24-03-14	BTIG Downgrades Cue Health to Neutral From Buy	MT
23-11-10	Goldman Sachs Trims Price Target on Cue Health to $0.50 From $0.75, Maintains Neutral Rating	MT
23-06-02	Goldman Sachs Downgrades Cue Health to Neutral From Buy, Trims Price Target to $0.75 From $2.75	MT
23-05-15	BTIG Cuts Cue Health's Price Target to $3 From $5, Maintains Buy Rating	MT
23-05-01	Goldman Sachs Adjusts Price Target on Cue Health to $3 From $3.50, Maintains Buy Rating	MT
22-11-14	Cowen Trims Price Target on Cue Health to $7 From $9, Maintains Outperform Rating	MT
22-10-21	Goldman Sachs Trims Cue Health's Price Target to $6 From $7, Maintains Buy Rating	MT
22-08-11	Morgan Stanley Trims Cue Health's Price Target to $8 From $10, Keeps Equalweight Rating	MT
22-07-18	Goldman Sachs Adjusts Price Target for Cue Health to $7 From $8.50, Maintains Buy Rating	MT
22-03-30	Morgan Stanley Adjusts Cue Health's Price Target to $11 from $12, Keeps Equalweight Rating	MT
21-10-19	CUE HEALTH : Morgan Stanley Starts Cue Health at Equalweight with $12 Price Target	MT
21-10-19	CUE HEALTH : Goldman Sachs Initiates Cue Health at Buy Rating With $19 Price Target	MT
21-10-19	CUE HEALTH : Cowen Starts Cue Health at Outperform With $14 Price Target	MT